JDD July Issue Highlights and Editor Picks
July JDD Highlights
Below are the issue highlights and Editor Picks for the July issue of JDD!
HDSM-Ax can be used in clinical research and practice to quantify changes in symptom severity in response to treatment in The Hyperhidrosis Disease Severity Measure-Axillary: Conceptualization and Development of Item Content.
The untapped potential of nanotechnology in the treatment of disorders …
July JDD Highlights
Below are the issue highlights and Editor Picks for the July issue of JDD!
HDSM-Ax can be used in clinical research and practice to quantify changes in symptom severity in response to treatment in The Hyperhidrosis Disease Severity Measure-Axillary: Conceptualization and Development of Item Content.
The untapped potential of nanotechnology in the treatment of disorders … Continue reading "JDD July Issue Highlights and Editor Picks"
In recent years there has been more and more research published which tries to elucidate the role that genetics, lifestyle and external factors like diet play in the pathogenesis, severity, and response to treatment of acne. One such study written by Amanda Suggs, MD and colleagues appears in the April 2018 issue of the Journal of Drugs in Dermatology. To gather data for this unique projec … 
PART 2
We at Next Steps are very excited to announce that the Executive Editor of our media partner, the Journal of Drugs in Dermatology, will be providing expert advice and tips on getting published. Karin Beehler, who has over 25 years of publishing experience, will share her extensive knowledge and expertise with our Next Steps readers in this 2-part series.
Peer review proces … 
PART 1
We at Next Steps are very excited to announce that the Executive Editor of our media partner, the Journal of Drugs in Dermatology, will be providing expert advice and tips on getting published. Karin Beehler, who has over 25 years of publishing experience, will share her extensive knowledge and expertise with our Next Steps readers in a 2-part series. Read part 2 here.
… 